Literature DB >> 3391224

Human immunodeficiency virus infection in multi-transfused patients with thalassaemia major.

P E Manconi1, C Dessí, G Sanna, F Argiolu, P Pellegrini-Bettoli, R Piro, O Masotti, A Cao.   

Abstract

We investigated the incidence, clinical and immunological characteristics of human immuno-deficiency virus (HIV) infection in a group of multi-transfused patients with thalassaemia major who were exposed to transfusion-associated HIV infection. Seropositivity to HIV by Western blot and immunofluorescence analysis was detected in 26 out of 590 patients. At a follow up 21-40 months later, none of these seropositive patients had developed acquired immuno-deficiency syndrome (AIDS), and six manifested the AIDS related complex (ARC). ARC was unusually mild and consisted of moderate laterocervical and submandibular lymph node enlargement associated with hypergammaglobulinaemia and a reduced CD4/CD8 ratio resulting from the decreased number of CD4 lymphocytes. These findings suggest that multi-transfused patients with thalassaemia major are relatively resistant to the development of severe manifestations of HIV infection, presumably because their immune status is relatively better preserved than that of other infected populations. Longer follow up is, however, necessary to determine whether the incidence of AIDS will be lower in this population or whether overt AIDS merely takes longer to develop.

Entities:  

Mesh:

Year:  1988        PMID: 3391224     DOI: 10.1007/bf00442701

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  27 in total

1.  Lymphadenopathy syndrome in two thalassemic patients after LAV contamination by blood transfusion.

Authors:  F Boiteux; E Vilmer; R Girot; J Y Muller; C Rouzioux; S Chamaret; L Montagnier
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

2.  Haemophilia, blood transfusion, and the AIDS virus.

Authors:  J S Lilleyman
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

3.  Impaired cell-mediated immunity in patients with classic hemophilia.

Authors:  M M Lederman; O D Ratnoff; J J Scillian; P K Jones; B Schacter
Journal:  N Engl J Med       Date:  1983-01-13       Impact factor: 91.245

4.  The communication of ELISA data from laboratory to clinician.

Authors:  D de Savigny; A Voller
Journal:  J Immunoassay       Date:  1980

5.  Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.

Authors:  J Kaplan; S Sarnaik; J Gitlin; J Lusher
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

6.  Acquired immunodeficiency syndrome in infants.

Authors:  G B Scott; B E Buck; J G Leterman; F L Bloom; W P Parks
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

7.  Generalized lymphadenopathy and T cell abnormalities in hemophilia A.

Authors:  J C Gill; J E Menitove; D Wheeler; R H Aster; R R Montgomery
Journal:  J Pediatr       Date:  1983-07       Impact factor: 4.406

8.  Transfusion-associated cytomegalovirus infection and acquired immune deficiency syndrome in an infant.

Authors:  K Shannon; E Ball; R L Wasserman; F K Murphy; J Luby; G R Buchanan
Journal:  J Pediatr       Date:  1983-12       Impact factor: 4.406

9.  The incidence rate of acquired immunodeficiency syndrome in selected populations.

Authors:  A M Hardy; J R Allen; W M Morgan; J W Curran
Journal:  JAMA       Date:  1985-01-11       Impact factor: 56.272

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.